EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 57 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $463,000 | -45.2% | 54,254 | -25.8% | 0.00% | -100.0% |
Q4 2020 | $845,000 | +45.4% | 73,121 | +5.6% | 0.00% | – |
Q3 2020 | $581,000 | -16.8% | 69,257 | -7.8% | 0.00% | -100.0% |
Q2 2020 | $698,000 | +84.2% | 75,138 | +7.0% | 0.00% | – |
Q1 2020 | $379,000 | -50.1% | 70,240 | +37.6% | 0.00% | -100.0% |
Q4 2019 | $760,000 | +2614.3% | 51,052 | +1753.7% | 0.00% | – |
Q3 2019 | $28,000 | 0.0% | 2,754 | +3.7% | 0.00% | – |
Q2 2019 | $28,000 | +600.0% | 2,657 | +785.7% | 0.00% | – |
Q2 2018 | $4,000 | -96.7% | 300 | -97.6% | 0.00% | – |
Q1 2018 | $122,000 | +12100.0% | 12,484 | +12260.4% | 0.00% | – |
Q4 2016 | $1,000 | – | 101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 393,975 | $120,162 | 0.00% |
XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
DRW Securities, LLC | 120,365 | $37 | 0.00% |
DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |